Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

2700 - Concerns of young women with breast cancer and theirs partners from chemotherapy to follow-up: a cross-sectional study


09 Oct 2016


Poster display


Laurence Vanlemmens


Annals of Oncology (2016) 27 (6): 497-521. 10.1093/annonc/mdw390


L. Vanlemmens1, A. Congard2, C. Duprez3, A. Baudry3, A. Lesur4, C. Loustalot5, C. Guillemet6, M. Leclercq7, C. Levy8, D. Carlier9, C. Lefeuvre-Plesse10, H. Simon11, J. Frenel12, P. Antoine3, V. Christophe3

Author affiliations

  • 1 Breast Cancer Department, Centre Oscar Lambret, 59020 - Lille/FR
  • 2 Centre De Recherche PsyclÉ (ea 3273), Aix-Marseille Université, Aix-en-Provence/FR
  • 3 Scalab Umr Cnrs 9193, Université de Lille, Villeneuve d'Ascq/FR
  • 4 Breast Cancer Department, Institut de Cancérologie de Lorraine, Nancy/FR
  • 5 Surgical Department, Centre Georges-François Leclerc (Dijon), Dijon/FR
  • 6 Medical Oncology, Centre Henri Becquerel, Rouen/FR
  • 7 -, -, Marcq En Baroeul/FR
  • 8 Oncology, Centre Francois Baclesse, Caen/FR
  • 9 Radio-chemotherapy, Clinique d'Imagerie du Pont Saint Vaast, Douai/FR
  • 10 Breast And Gynecologic Oncology, Centre Eugene - Marquis, Rennes/FR
  • 11 Medical Oncology, C.H.U. Brest - Hôpital Morvan, Brest/FR
  • 12 Medical Oncology, ICO Institut de Cancerologie de l'Ouest René Gauducheau, 44805 - St. Herblain/FR


Abstract 2700


Better understanding the concerns of couples facing cancer appears crucial for care quality. This study aims to clarify the subjective experience in couples in which the woman is diagnosed with early breast cancer at a young age ( 


491 couples (28.7% of which non-metastatic breast cancer women were under chemotherapy, 10.2% under trastuzumab, 33.9% under hormone therapy and 28.1% under follow-up) completed a self-administered questionnaire (for patient : YW-BCI36 and for partner : corresponding version : partner YW-BCI36 (Christophe and al. Health Qual Life Outcomes 2015)), scale to identify respective subjective experience of the disease (36 items, 8 dimensions).


Patients reported more difficulties than partners in the management of child(ren) and the everyday life, body image and sexuality, negative affectivity and apprehension about the future, career management, and finances. Although the difficulties were generally more marked during chemotherapy and Trastuzumab than during hormone therapy and follow-up, the negative affectivity and apprehension about the future was high in every stage of treatment, especially in patients. The partners reported more difficulties in sharing with their close relatives, these difficulties increasing over time and also in patients. No difference appeared between patients and partners in the couple cohesion and deterioration of relationships with relatives.


Couples' difficulties are particularly severe in the early care pathway and decrease over time, reflecting a progressive adjustment. A longitudinal study will substantiate this finding and allow to better identify some explanatory processes of these differences and similarities in the daily experience of the disease in couples.

Clinical trial identification

Legal entity responsible for the study

Centre Oscar Lambret


This paper presents independent research funded by the Ligue Nationale contre le Cancer, the Conseil Régional du Nord-Pas de Calais, the Prix Ruban Rose 2010, and Sanofi, Roche and Novartis


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings